EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prolactinomas: Clinical and Epidemiological Aspects

Nikolaos Mavritsakis, Raul Ioan Muntean, Vasile Emil Ursu, Razvan Susan, Monica Susan, Gina Gogean Groza, Razvan Gheorghe Rusu, Dan Boariu, Cristina Maria Man, Elena Ionescu

BRAIN. Broad Research in Artificial Intelligence and Neuroscience · 05.07.2024 · 15 (2) · 210-224

DOI: 10.18662/brain/15.2/573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BRAIN. Broad Research in Artificial Intelligence and Neuroscience, online erschienen am 05.07.2024. Verfasst von Nikolaos Mavritsakis und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research delves into the epidemiology, clinical manifestations, and management of hyperprolactinemia, particularly focusing on prolactin-secreting pituitary adenomas, or prolactinomas, in Dolj County, a region historically underrepresented in medical literature. Hyperprolactinemia, a prevalent endocrine disorder, arises from excessive prolactin secretion by the pituitary gland's lactotrope cells and presents a diverse clinical picture. The most significant etiological contributors identified are prolactinomas, accounting for approximately 39% of all secretory pituitary tumors. In light of hyperprolactinemia's substantial morbidity and prevalence, this study underscores the necessity of comprehensive understanding of its regional epidemiology and clinical presentations. Our methodology incorporated collecting retrospective data across various medical facilities in Dolj, ensuing a meticulous analysis of clinical features, paraclinical investigation outcomes, and therapeutic responses among patients with prolactinomas. Emphasis was placed on discerning risk factors, demographic characteristics, and associated comorbidities to encapsulate the full spectrum of these tumors' impact within the community. Preliminary results suggest a nuanced incidence rate of prolactinomas within Dolj, with specific demographic and clinical trends potentially distinct from those reported in wider literature. These findings stress the critical role of localized studies in enhancing screening, diagnostic, and therapeutic protocols. Ultimately, this investigation offers critical insights into the epidemiology and symptomatology of prolactinomas in Dolj, significantly augmenting existing literature and informing regional medical practices.

Zitieren

APA

Mavritsakis, N., Muntean, R. I., Ursu, V. E., Susan, R., Susan, M., Groza, G. G., Rusu, R. G., Boariu, D., Man, C. M., & Ionescu, E. (2024). Prolactinomas: Clinical and Epidemiological Aspects. BRAIN. Broad Research in Artificial Intelligence and Neuroscience, 15(2), 210-224. https://doi.org/10.18662/brain/15.2/573

Vancouver

Mavritsakis N, Muntean RI, Ursu VE, Susan R, Susan M, Groza GG, et al. Prolactinomas: Clinical and Epidemiological Aspects. BRAIN. Broad Research in Artificial Intelligence and Neuroscience. 2024;15(2):210-224. doi:10.18662/brain/15.2/573

BibTeX
@article{Mavritsakis2024,
  author = {Mavritsakis, Nikolaos and Muntean, Raul Ioan and Ursu, Vasile Emil and Susan, Razvan and Susan, Monica and Groza, Gina Gogean and Rusu, Razvan Gheorghe and Boariu, Dan and Man, Cristina Maria and Ionescu, Elena},
  title = {Prolactinomas: Clinical and Epidemiological Aspects},
  journal = {BRAIN. Broad Research in Artificial Intelligence and Neuroscience},
  year = {2024},
  volume = {15},
  number = {2},
  pages = {210--224},
  doi = {10.18662/brain/15.2/573}
}
Kostenlos starten →